Streetbeat News

Stock Prices

DIS

PLTR

QQQ

RIVN

SPY

Wall Street shows mixed reactions as earnings from Disney and Palantir disappoint, with futures indicating a varied open. Disney's unexpected pre-market drop, despite profit, and Palantir's negative impact on tech stocks are in focus. Upcoming speeches by Federal Reserve officials and economic reports are also anticipated. SPDR S&P 500 ETF Trust and Invesco QQQ ETF show slight pre-market movements. Analysts remain optimistic about the bull market's return, citing lower interest rates and AI's ongoing relevance. Stocks like Lucid Group and Lumentum Holdings react to earnings announcements, while Rivian gains on Apple partnership rumors.

Portfolio Pulse from Shanthi Rexaline

May 07, 2024 | 11:26 am

TSLA

Tesla's stock is trading lower following a report that its April sales of China-made vehicles decreased by 18% compared to the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:26 am

AUDC

AudioCodes shares are trading lower following the announcement of Q1 financial results that did not meet expectations.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:25 am

OSCR

Oscar Health's stock price increased following the announcement of their Q1 sales results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:23 am

CROX

Crocs shares are trading lower following the release of their Q1 financial results, indicating a negative market reaction to the company's performance.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:19 am

TDG

TransDigm has raised its FY24 outlook, with sales now expected to be between $7.68B-$7.80B, up from the prior $7.58B-$7.76B range, and adjusted EPS forecasted to be $31.75-$33.09, up from the previous $29.97-$31.73 range. These figures surpass the $7.73B sales estimate and are in line with the $31.86 EPS estimate.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:18 am

BMY

ENOV

GRI

TVGN

The article highlights the top 4 oversold health care stocks, suggesting potential investment opportunities. Tevogen Bio, Enovis Corporation, GRI Bio, and Bristol-Myers Squibb are identified based on their low RSI values, indicating they may be undervalued. Recent company developments and stock performance are discussed for each.

Portfolio Pulse from Avi Kapoor

May 07, 2024 | 11:18 am

CELH

Celsius Holdings' shares dropped following the announcement of Q1 sales results that fell below market expectations.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:17 am

TDG

TransDigm Group Incorporated (TDG) reported Q2 2024 adjusted EPS of $7.99, surpassing the $7.42 estimate, with sales of $1.919B also beating the $1.880B estimate. This represents a 20.54% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:16 am

DDOG

Datadog shares are trading lower following the announcement of their Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:14 am